Back to trial detailsIntake questionnaire
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Applying to RAO Research LLC · Oklahoma City, Oklahoma
Answer a few short questions to share with the research team.
0 of 4 answered